
Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data
Author(s) -
Alisa Stöber,
Johanna I. Lutter,
Larissa Schwarzkopf,
F.W. Kirsch,
Anja Schramm,
Claus Vogelmeier,
Reiner Leidl
Publication year - 2021
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s313711
Subject(s) - medicine , copd , exacerbation , quality of life (healthcare) , obstructive lung disease , visual analogue scale , minimal clinically important difference , health related quality of life , pulmonary function testing , lung function , eq 5d , gold standard (test) , pulmonary disease , disease , physical therapy , lung , randomized controlled trial , nursing
Real-world evidence on the impact of forced expiratory volume in one second (FEV 1 ) and exacerbations on health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) is sparse especially with regard to GOLD ABCD groups. This study investigates how changes in FEV 1 and exacerbations affect generic and disease-specific HRQoL in COPD patients over one year.